Effect of Clopidogrel by Smoking Status on Secondary Stroke Prevention.

Authors

Bruce Ovbiagele
Jing Wang
S Claiborne Johnston
Anxin Wang
David Z. Wang, Neurovascular Division, Department of Neurology, Barrow Neurological Institute, St Joseph Hospital and Medical Center, Phoenix, AZ, USA.Follow
Yongjun Wang
Xingquan Zhao
Yilong Wang

Document Type

Article

Medical Subject Headings

Aspirin; Clinical Trials as Topic; Clopidogrel; Datasets as Topic; Drug Therapy, Combination; Humans; Kaplan-Meier Estimate; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Secondary Prevention; Smoking; Stroke; Ticlopidine

Publication Date

1-17-2017

Publication Title

Circulation

ISSN

1524-4539

Volume

135

Issue

3

First Page

315

Last Page

316

PubMed ID

28093495

Digital Object Identifier (DOI)

10.1161/CIRCULATIONAHA.116.024957

Recommended Citation

Ovbiagele, Bruce; Wang, Jing; Johnston, S Claiborne; Wang, Anxin; Wang, David Z.; Wang, Yongjun; Zhao, Xingquan; and Wang, Yilong, "Effect of Clopidogrel by Smoking Status on Secondary Stroke Prevention." (2017). Neurology. 1872.
https://scholar.barrowneuro.org/neurology/1872